CYCLOSPORINE-A AND FK506 BLOCK INDUCTION OF THE EPSTEIN-BARR-VIRUS LYTIC CYCLE BY ANTIIMMUNOGLOBULIN

被引:25
作者
GOLDFELD, AE
LIU, PF
LIU, SF
FLEMINGTON, EK
STROMINGER, JL
SPECK, SH
机构
[1] WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA
[2] WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA
[3] DANA FARBER CANC INST, DIV TUMOR VIROL, BOSTON, MA 02115 USA
[4] DANA FARBER CANC INST, DEPT MED, BOSTON, MA 02115 USA
关键词
D O I
10.1006/viro.1995.1247
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Epstein-Barr virus (EBV) BZLF1 gene is expressed early upon induction of the viral lytic cycle and its protein product is unique in its ability to disrupt viral latency in some latently infected cell lines. Anti-immunoglobulin (anti-Ig) treatment of the Burkitt's lymphoma cell line Akata, which bears surface IgG, has previously been shown to synchronously induce transcription of the BZLF1 gene (K. Takada and Y. One, 1989, J. Virol. 63, 445-449). We have previously shown that anti-Ig induction of Akata cells activates expression of the tumor necrosis factor alpha (TNF-alpha) gene via a calcineurin-dependent mechanism (Goldfeld et al., 1992, Proc. Natl. Acad. Sci. USA 89, 12198-12201). Here, we report that anti-Ig induction of the EBV lytic cycle in Akata cells can be blocked by the immunosuppressants cyclosporin A and FK506. Furthermore, we demonstrate that synergistic induction by phorbol ester and calcium ionophore of a BZLF1 promoter-driven reporter construct in an EBV-negative BL cell line can be inhibited by addition of cyclosporin A. Thus, analogous to activation of TNF-alpha gene in Akata cells, anti-Ig induction of the BZLF1 promoter is most likely mediated by calcineurin and probably involves translocation to the nucleus of a transcription factor sequestered in the cytoplasm. As such, immunosuppressants may be useful probes for dissecting a cell activation pathways involved in regulating EBV gene transcription. (C) 1995 Academic Press, Inc.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 46 条
[31]   THE SPLICED BZLF1 GENE OF EPSTEIN-BARR VIRUS (EBV) TRANSACTIVATES AN EARLY EBV PROMOTER AND INDUCES THE VIRUS PRODUCTIVE CYCLE [J].
ROONEY, CM ;
ROWE, DT ;
RAGOT, T ;
FARRELL, PJ .
JOURNAL OF VIROLOGY, 1989, 63 (07) :3109-3116
[32]  
ROWE M, 1989, ADV VIRAL ONCOL, V8, P237
[33]   CHEMISTRY AND BIOLOGY OF THE IMMUNOPHILINS AND THEIR IMMUNOSUPPRESSIVE LIGANDS [J].
SCHREIBER, SL .
SCIENCE, 1991, 251 (4991) :283-287
[34]   ANALYSIS OF THE BZLF1 PROMOTER OF EPSTEIN-BARR-VIRUS - IDENTIFICATION OF AN ANTIIMMUNOGLOBULIN RESPONSE SEQUENCE [J].
SHIMIZU, N ;
TAKADA, K .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3240-3245
[35]  
SPECK SH, 1989, ADV VIRAL ONCOL, V8, P133
[36]   TRANS ACTIVATION OF THE LATENT EPSTEIN-BARR-VIRUS (EBV) GENOME AFTER TRANSFECTION OF THE EBV DNA FRAGMENT [J].
TAKADA, K ;
SHIMIZU, N ;
SAKUMA, S ;
ONO, Y .
JOURNAL OF VIROLOGY, 1986, 57 (03) :1016-1022
[37]   SYNCHRONOUS AND SEQUENTIAL ACTIVATION OF LATENTLY INFECTED EPSTEIN-BARR VIRUS GENOMES [J].
TAKADA, K ;
ONO, Y .
JOURNAL OF VIROLOGY, 1989, 63 (01) :445-449
[39]   EXPRESSION OF THE BZLF1 LATENCY-DISRUPTING GENE DIFFERS IN STANDARD AND DEFECTIVE EPSTEIN-BARR VIRUSES [J].
TAYLOR, N ;
COUNTRYMAN, J ;
ROONEY, C ;
KATZ, D ;
MILLER, G .
JOURNAL OF VIROLOGY, 1989, 63 (04) :1721-1728
[40]  
THOMAS JA, 1991, ADV CANCER RES, V57, P421